Mutations in the NCF4 gene encoding p40phox, a less well understood subunit of the NADPH oxidase complex, were first described in CGD with abnormal neutrophil function in 2009, which disproved the view that p40phox was not essential for NADPH oxidase activity (18). This evidence concerns the gene FMO5 and chronic granulomatous disease.